Concise informed consent to increase data and biospecimen access may accelerate innovative Alzheimer's disease treatments

INTRODUCTION: Informed consent forms that restrict the distribution of data and samples have been an impediment to advancing Alzheimer's disease (AD) understandings and treatments. The Coalition Against Major Disease public-private partnership developed concise addenda to responsibly broaden da...

Descripción completa

Detalles Bibliográficos
Autores principales: Hake, Ann M., Dacks, Penny A., Arnerić, Stephen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671623/
https://www.ncbi.nlm.nih.gov/pubmed/29124112
http://dx.doi.org/10.1016/j.trci.2017.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671623/
https://www.ncbi.nlm.nih.gov/pubmed/29124112
http://dx.doi.org/10.1016/j.trci.2017.08.003

Ejemplares similares